WallStSmart

NewGenIvf Group Limited Class A Ordinary Shares (NIVF)vsUniversal Health Services Inc (UHS)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Universal Health Services Inc generates 379418% more annual revenue ($17.36B vs $4.58M). UHS leads profitability with a 8.6% profit margin vs 3.8%. UHS earns a higher WallStSmart Score of 76/100 (B+).

NIVF

Buy

51

out of 100

Grade: C-

Growth: 4.0Profit: 3.0Value: 6.7Quality: 5.0

UHS

Strong Buy

76

out of 100

Grade: B+

Growth: 7.3Profit: 7.0Value: 10.0Quality: 7.5
Piotroski: 6/9Altman Z: 2.97
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

NIVFUndervalued (+100.0%)

Margin of Safety

+100.0%

Fair Value

$3305.41

Current Price

$2.01

$3303.40 discount

UndervaluedFair: $3305.41Overvalued
UHSUndervalued (+78.6%)

Margin of Safety

+78.6%

Fair Value

$1081.08

Current Price

$186.72

$894.36 discount

UndervaluedFair: $1081.08Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

NIVF1 strengths · Avg: 10.0/10
Price/BookValuation
0.0x10/10

Reasonable price relative to book value

UHS4 strengths · Avg: 8.8/10
P/E RatioValuation
8.1x10/10

Attractively priced relative to earnings

Return on EquityProfitability
21.3%9/10

Every $100 of equity generates 21 in profit

Price/BookValuation
1.6x8/10

Reasonable price relative to book value

EPS GrowthGrowth
42.7%8/10

Earnings expanding 42.7% YoY

Areas to Watch

NIVF4 concerns · Avg: 3.3/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$983,3203/10

Smaller company, higher risk/reward

Return on EquityProfitability
1.6%3/10

ROE of 1.6% — below average capital efficiency

Profit MarginProfitability
3.8%3/10

3.8% margin — thin

UHS0 concerns · Avg: 0/10

No major concerns identified

Comparative Analysis Report

WallStSmart Research

Bull Case : NIVF

The strongest argument for NIVF centers on Price/Book.

Bull Case : UHS

The strongest argument for UHS centers on P/E Ratio, Return on Equity, Price/Book. PEG of 1.29 suggests the stock is reasonably priced for its growth.

Bear Case : NIVF

The primary concerns for NIVF are EPS Growth, Market Cap, Return on Equity. Thin 3.8% margins leave little buffer for downturns.

Bear Case : UHS

No major red flags identified for UHS, but monitor valuation.

Key Dynamics to Monitor

UHS carries more volatility with a beta of 1.26 — expect wider price swings.

UHS is growing revenue faster at 9.1% — sustainability is the question.

Monitor MEDICAL CARE FACILITIES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

UHS scores higher overall (76/100 vs 51/100). NIVF offers better value entry with a 100.0% margin of safety. Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

NewGenIvf Group Limited Class A Ordinary Shares

HEALTHCARE · MEDICAL CARE FACILITIES · USA

NewGenIvf Group Limited (NIVF) is a prominent provider in the reproductive health sector, specializing in advanced fertility solutions and innovative in vitro fertilization (IVF) services. The company is dedicated to enhancing success rates in assisted reproductive techniques and addresses the growing global demand for fertility treatments through a well-established network of clinics and strategic partnerships. Positioned for growth within a rapidly expanding market, NIVF is well-equipped to capitalize on emerging opportunities, reinforcing its commitment to helping individuals and couples realize their dreams of parenthood.

Universal Health Services Inc

HEALTHCARE · MEDICAL CARE FACILITIES · USA

UnitedHealth Group Incorporated is an American for-profit multinational managed healthcare and insurance company based in Minnetonka, Minnesota. It offers health care products and insurance services.

Visit Website →

Want to dig deeper into these stocks?